Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood.
Mycobacterial cervical adenitis is an uncommon disease in children in Finland. During 10 years, from 1977-1986, its incidence was of the order of 0.3/year/100,000 children. Of the 12 bacteriologically verified cases, M. avium-intracellulare was isolated in nine, M. malmoense in two and M. tuberculosis in only one case. Neonatal BCG vaccination seemed to protect children against non-tuberculous mycobacterial infection, especially at 1-4 years of age. In Sweden, where neonatal BCG vaccination has been discontinued, the incidence of non-tuberculous mycobacterial adenitis is at least 30 times greater.
D000293:Adolescent; D001500:BCG Vaccine; D002648:Child; D002675:Child, Preschool; D005260:Female; D005387:Finland; D006801:Humans; D007223:Infant; D008199:Lymphadenitis / Q000382:microbiology / Q000517:prevention & control*; D008297:Male; D009164:Mycobacterium Infections / Q000517:prevention & control*; D009165:Mycobacterium Infections, Nontuberculous / Q000382:microbiology / Q000517:prevention & control*; D009162:Mycobacterium avium / Q000302:isolation & purification; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D009333:Neck; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification; D013548:Sweden; D014388:Tuberculosis, Lymph Node / Q000382:microbiology / Q000517:prevention & control*
D001500:BCG Vaccine